Prilosec Articles
AstraZeneca EPS set to fall in 2003
3 February 2003
AstraZeneca to issue earnings warning?
3 February 2003
Tokyo pharma stocks - week to Jan 20
27 January 2003
Stock Commentary week to Jan 13 - Europe
20 January 2003
Prilosec market share slumps 50% in USA
20 January 2003
AstraZeneca shares hit three-month low
20 January 2003
Eon's generic Prilosec is approved in USA
13 January 2003
Celebrex as good as two drugs for ulcers
6 January 2003
US consumers sue over Prilosec and Visudyne
19 August 2002
Schwarz profits down 74% in 1st half
12 August 2002
AstraZeneca sales rise 6.9% in 2nd quarter
5 August 2002
Francisco Durban moving into generics
5 August 2002
Merck KGaA sales are hit by generics
29 July 2002
New launches planned at Bayvit
1 July 2002
Axcan says Photofrin "excellent" in new use
1 July 2002
US FDA to take advice on OTC version of Prilosec
1 July 2002
Stock Commentary - Europe
10 June 2002
AstraZeneca: US Losec patent disallowed
29 April 2002
Stock Commentary - New York
22 April 2002
World drug sales up 12% in year to Feb
22 April 2002
France's top-selling Rx drugs in 2001
15 April 2002
Pretax profits leap 41% at Altana
1 April 2002
P&G expecting healthy EPS growth
25 March 2002
AstraZeneca forecasts growth in Spain
25 March 2002
Arimidex launched for early breast cancer
11 March 2002
GSK to appeal bupropion ruling
11 March 2002
Prilosec to get OK for OTC use this year?
4 March 2002
Nexium tops rival in GERD maintenance trial
4 March 2002
AstraZeneca urged over Prilosec trial delays
25 February 2002
US push for generics of "gold-standard" drugs
25 February 2002
Stock Commentary - Europe
11 February 2002
AstraZeneca confident about overcoming loss of Prilosec revenues
11 February 2002
Indian bulk drug price moves boost MNCs
11 February 2002
Expensive new GERD drugs "actually more cost-effective"
28 January 2002
Stock Commentary - Europe
14 January 2002
US GAO sees no big savings from Rx cards
14 January 2002
Stock Commentary - Europe
13 December 2001
Merck & Co issues profit warning
12 December 2001
SPAN seeking US FTC probe of aaiPharma
10 December 2001
"Robust" year for AstraZeneca
5 December 2001
World drug sales up 11% in year to Sept
3 December 2001
Stock Commentary - Europe
29 November 2001
Delay expected for Altana's roflumilast?
28 November 2001
Pantoprazole sales leap 144% as Altana raises 2001 profit forecast
27 November 2001
FDA slammed over Rx "applesauce" data
20 November 2001
Andrx generic Prilosec approved in USA
19 November 2001
US insurer sponsors generics promotion
16 November 2001
Stock Commentary - Europe
8 November 2001
US FDA slammed over generic Prilosec delays
8 November 2001
AstraZeneca wins Losec patent case in Norway
1 November 2001
Date set for Prilosec patent suit in USA
25 October 2001
Nexium comparative data provides further boost to AstraZeneca
10 October 2001
World retail drug sales grew 11% in 12 months to July 2001, reports IMS
28 September 2001
Generics industry poised for gold rush as blockbusters lose protection
13 September 2001
ICN Pharma earnings take a downturn
3 August 2001
AstraZeneca sales rise 8%, Nexium doing well
26 July 2001
aai Pharma patents may block generic Prilosec
23 July 2001
Axcan gets priority review for Photofrin in Canada
19 July 2001
US state seniors Rx costs compared globally
18 July 2001
Dr Reddy's get tentative OK for two drugs in USA
29 June 2001
US seniors' Rx cost rises "are double inflation"
15 June 2001
Nexium makes strong start in USA
24 May 2001
US consumer groups pledge more lawsuits
15 May 2001
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
